Erratum
Erratum
Erratum to: Hepatobiliary Surg Nutr 2014;3:82-6;
Erratum to: Hepatobiliary Surg Nutr 2014;3:87-90;
Erratum to: Hepatobiliary Surg Nutr 2014;3:91-2;
Erratum to: Hepatobiliary Surg Nutr 2014;3:93-4;
Erratum to: Hepatobiliary Surg Nutr 2014;3:95-7;
Erratum to: Hepatobiliary Surg Nutr 2014;3:98-101.
In the published issue on the journal Hepatobiliary Surgery and Nutrition (Vol 3, No 2), pages 82-101 (1-6), the column title of “Hepatocellular Carcinoma Column: Editorial” was mistakenly published as “Hepatocellular Carcinoma Column”.
The publisher regrets the error.
Reference
- Nomoto S, Hishida M, Inokawa Y, et al. Management of hepatocellular carcinoma should consider both tumor factors and background liver factors. Hepatobiliary Surg Nutr 2014;3:82-6. [PubMed]
- Yeh YT, Dai HY, Chien CY. Amplification of MPZL1/PZR gene in hepatocellular carcinoma. Hepatobiliary Surg Nutr 2014;3:87-90. [PubMed]
- Facciorusso A, Barone M.. Glucose intolerance and hepatocellular carcinoma: recent findings for old diseases. Hepatobiliary Surg Nutr 2014;3:91-2. [PubMed]
- Shaikh F, Goff LW. Decoding hepatocellular carcinoma: the promise of microRNAs. Hepatobiliary Surg Nutr 2014;3:93-4. [PubMed]
- Lee YY, Mok MT, Cheng AS. Dissecting the pleiotropic actions of HBx mutants against hypoxia in hepatocellular carcinoma. Hepatobiliary Surg Nutr 2014;3:95-7. [PubMed]
- Eiró N, Vizoso FJ. Importance of the tumor/stromal interactions in prognostic from hepatocellular carcinoma. Hepatobiliary Surg Nutr 2014;3:98-101. [PubMed]
Cite this article as: Editorial Team. Erratum. Hepatobiliary Surg Nutr 2014;3(3):165. doi: 10.3978/j.issn.2304-3881.2014.06.05
